The Standard & Poor’s 500 touches 3,000 for the first time since early March as shutdown protocols continue to unwind and more drug companies chase vaccines.
The Standard & Poor’s 500 touches 3,000 for the first time since early March as shutdown protocols continue to unwind and more drug companies chase vaccines.